WEBINARS
Our webinars allow users to learn from experts and earn continuing education credits on industry topics, progress in research, services available, and more.
Show More
Sino Biological
Sino Biological, Inc. is a global leader in manufacturing affordable, high-quality reagents, including recombinant proteins, antibodies and cDNA clones-all in-house. We provide a one-stop shop for researchers and pharmaceutical companies around the world, helping our customers obtain the best reagents in the needed amounts to accelerate the pace of discovery and improve human health.
Show More
-
AUG 10, 2023 | 8:00 AMC.E. CREDITS
Antibody therapeutics is a fast-growing market boosted by developments in bispecific antibodies and in newly emerging tetra-specific antibodies. With the ability to recruit a combination of... -
JUN 14, 2023 | 8:00 AMC.E. CREDITS
Influenza is a highly contagious respiratory illness that affects millions of people worldwide each year. The influenza virus is constantly evolving, making it difficult to predict and preve...
-
APR 25, 2023 | 8:00 AMC.E. CREDITS
Date: April 25, 2023 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Several promising immunotherapies have emerged in recent decades due to advances in cancer immunology. The paradigm o...
-
NOV 10, 2022 | 8:00 AMC.E. CREDITS
Date: November 10, 2022 Time: 8:00am (PST), 11:00am (EST), 5:00pm (CET) Single B cell screening is a powerful and efficient strategy for generating antigen-specific monoclonal antibodies. Di...
-
OCT 20, 2022 | 8:00 AMC.E. CREDITS
Date: October 20, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Over the past three decades, baculovirus expression vector system (BEVS) has become one of the most powerful and robus...
-
MAY 17, 2022 | 7:00 AMC.E. CREDITS
Date: May 17, 2022 Time: 7:00am (PDT), 10:00am (EDT), 4:00pm (CEST) Monoclonal antibody (mAb) is generated from a single clone of an antibody-producing cell and recognizes one specific epitop...
-
AUG 27, 2020 | 7:00 AM
DATE: August 27, 2020 TIME: 7:00am PT Novel anti-viral medications, including biologics and small molecule inhibitors, as well as serologic diagnostic tool sets are in urgent demand to fight...
-
JUN 17, 2020 | 10:30 AM
The COVID-19 pandemic is caused by a newly discovered coronavirus, SARS-CoV-2. To characterize and detect this new virus, antibodies to support scientific research, diagnosis and vaccine dev...
-
APR 30, 2024Immuno-Oncology Virtual Event Series 2024
-
MAY 07, 20243rd International Biosecurity Virtual Symposium
-
JUN 06, 2024The Future of Scientific Conferencing
- See More
-
APR 19, 2024
-
APR 19, 2024
- See More
